Last updated on March 2020

Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines

Brief description of study

This is a phase 3, multicenter, open-label study to evaluate the safety of QM1114-DP for the long term treatment of moderate to severe Glabellar (Frown) Lines (GL) and Lateral Canthal Lines (Crow's Feet and LCL).

Clinical Study Identifier: NCT04225260

Find a site near you

Start Over


Santa Rosa, CA United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.